BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2025 3:09:36 AM | Browse: 177 | Download: 606
 |
Received |
|
2024-11-19 08:52 |
|
Peer-Review Started |
|
2024-11-19 08:53 |
|
First Decision by Editorial Office Director |
|
2025-03-08 05:30 |
|
Return for Revision |
|
2025-03-08 05:30 |
|
Revised |
|
2025-03-26 08:49 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-04-22 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-04-22 06:12 |
|
Articles in Press |
|
2025-04-22 06:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-30 09:01 |
|
Publish the Manuscript Online |
|
2025-06-06 03:09 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ning Wang, Fei-Tian Min, Wei-Bo Wen and Huan-Tian Cui |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82405223 |
| Yunling Scholars Program |
XDYC-YLXZ-2022-0027 |
|
| Corresponding Author |
Huan-Tian Cui, PhD, The First School of Clinical Medicine, Yunnan university of Chinese Medicine, No. 1076 Yuhua Road, Chenggong District, Kunming 650000, Yunnan Province, China. 1762316411@qq.com |
| Key Words |
Hepatocellular carcinoma; Stemness; Sorafenib resistance; Long non-coding RNA KIF9-AS1; Short stature homeobox 2; N6-methyladenosine |
| Core Tip |
Yu et al present evidence showing that m6A-modified long non-coding RNA KIF9-AS1 drives the progression of hepatocellular carcinoma (HCC) and reveal novel molecular mechanisms underlying this process. The m6A modification, mediated by modification involves methyltransferase-like 3 and insulin-like growth factor insulin-like growth factor 2 mRNA-binding protein 1, stabilizes and upregulates KIF9-AS1 expression. In turn, KIF9-AS1 enhances the stability and expression of SHOX2 by promoting its deubiquitination via ubiquitin-specific peptidase 1, which strengthens stemness and contributes to sorafenib resistance in HCC cells. Future studies should further validate KIF9-AS1 as a potential diagnostic biomarker for HCC and explore its therapeutic applications in HCC treatment. |
| Publish Date |
2025-06-06 03:09 |
| Citation |
Wang N, Min FT, Wen WB, Cui HT. Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA. World J Gastroenterol 2025; 31(21): 103184
|
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i21/103184.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i21.103184 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
